TeVido BioDevices received a mention in this press release of: “The global 3D bioprinting market is expected to reach USD 2.6 billion by 2024 ”
Summary: LONDON, July 4, 2018 /PRNewswire/ — 3D Bioprinting Market Size, Share & Trends Analysis Report By Technology (Magnetic Levitation, Inkjet Based, Syringe Based, Laser Based), By Application, And Segment Forecasts, 2012 – 2024
Download the full report: https://www.reportbuyer.com/product/5399292
The global 3D bioprinting market is expected to reach USD 2.6 billion by 2024, according to a new report by Grand View Research, Inc. Growing use of 3D printing in cosmetic surgery and drug testing coupled with increasing demand for 3D bio-printed organs is expected to drive the market growth during the forecast period.
Currently, 3D bioprinting is used for printing medical instruments, prosthetics, and dental & bone implants. However, its application is expected to grow in pharmaceutical manufacturing as it helps in reducing the overall cost of drug manufacturing.